Tag: Daiichi Sankyo
First patient enrolled in Daiichi Sankyo’s ELIMINATE-AF edoxaban study
The first patient has been enrolled into Daiichi Sankyo’s ELIMINATE-AF study. The multinational, randomised phase 3b study will explore the safety and efficacy of...
Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban
The first patient has been enrolled into Daiichi Sankyo’s ENTRUST-AF PCI study. The multinational, randomised phase 3b study will evaluate a treatment regimen based...
Daiichi Sankyo PREFER in AF registry suggests increased stroke risk among...
Daiichi Sankyo has announced data from new sub-analyses of the Prevention of thromboembolic events—European Registry in Atrial Fibrillation (PREFER in AF) patient registry, which...